December 12, 2017 — Bayer and Johnson & Johnson have been slammed with a $28 million jury verdict in favor of a woman who suffered bleeding after taking Xarelto.
After a 1-month trial in the Philadelphia Court of Common Pleas, the jury awarded $1.8 million in compensatory damages to plaintiff Lynn Hartman, plus another $26 million in punitive damages.
Hartman used Xarelto for about 1 year, and she filed a lawsuit after she was hospitalized with severe gastrointestinal bleeding in 2014.
The lawsuit accused Bayer and Johnson & Johnson of failing to warn about the risk of severe bleeding. Unlike other blood-thinners on the market, such as Pradaxa and warfarin, Xarelto lacks a reversal agent to counteract its blood-thinning effects. In an emergency, doctors may struggle to stop uncontrollable bleeding.
Hartman required 4 blood transfusions to counteract Xarelto and stop her gastrointestinal bleeding. She has not experienced any similar problems after switching to a different blood-thinning medication.
Xarelto has been linked to at least 370 deaths, according to the FDA. Bayer and Johnson & Johnson are facing approximately 18,000 federal lawsuits, plus another 1,500 lawsuits.
Do I have a Xarelto Lawsuit?
The Schmidt Firm, PLLC is currently accepting Xarelto induced injury cases in all 50 states. If you or somebody you know has been diagnosed with severe bleeding, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.